1. The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition
    Anna Kuzevanova et al, 2022, Biomedicines CrossRef
  2. Clinical significance of high mobility group box 1/toll-like receptor 4 in obese diabetic patients
    Shuai Liu et al, 2022, Endocrine Journal CrossRef
  3. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities
    Prasanna Srinivasan Ramalingam et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  4. Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?
    Ornella Franzese et al, 2021, International Journal of Molecular Sciences CrossRef
  5. A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling
    Hideaki Abe et al, 2021, Medicines CrossRef
  6. miR‑142‑3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1
    Hui Dong et al, 2021, Experimental and Therapeutic Medicine CrossRef
  7. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
    A K M Nawshad Hossian et al, 2021, Scientific Reports CrossRef

  8. LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1


    Ruo-Tian Wang et al, 2020, OncoTargets and Therapy CrossRef
  9. HMGB1: a double-edged sword and therapeutic target in the female reproductive system
    Yu Ren et al, 2023, Frontiers in Immunology CrossRef
  10. HMGB1’in Kanser ve Tedavisiyle İlişkisi
    Eylem TAŞKIN GÜVEN et al, 2019, Düzce Üniversitesi Bilim ve Teknoloji Dergisi CrossRef
  11. Research Progress of High-Mobility Group Box Protein B1 in Respiratory Diseases
    润玉 邵, 2021, Advances in Clinical Medicine CrossRef
  12. High Mobility Group Box 1 in Human Cancer
    Bernardo L. Rapoport et al, 2020, Cells CrossRef
  13. The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
    Rina Masadah et al, 2021, Cancers CrossRef
  14. IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung Adenocarcinoma
    Lorenzo Islas-Vazquez et al, 2020, Biology CrossRef
  15. Sufentanil Suppresses Cell Carcinogenesis Via Targeting miR-186-5p/HMGB1 Axis and Wnt/β-Catenin Pathway in Non-Small-Cell Lung Cancer
    Di Liu et al, 2024, Molecular Biotechnology CrossRef
  16. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
    Yanhua Zuo et al, 2023, Pathology and Oncology Research CrossRef
  17. Regulation of Molecular Targets in Osteosarcoma Treatment
    Betul Celik et al, 2022, International Journal of Molecular Sciences CrossRef
  18. Proteomic profiling and identification of significant markers from high-grade osteosarcoma after cryotherapy and irradiation
    Rashmi Madda et al, 2020, Scientific Reports CrossRef
  19. High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1
    Wei-Lun Liu et al, 2021, International Journal of Molecular Sciences CrossRef
  20. HMGB1 Promotes Lymphangiogenesis through the Activation of RAGE on M2 Macrophages in Laryngeal Squamous Cell Carcinoma
    Caili Su et al, 2022, Disease Markers CrossRef